Featured Research

from universities, journals, and other organizations

Healthy, Younger Adults Could Be At Risk For Heart Disease

Date:
January 13, 2009
Source:
UT Southwestern Medical Center
Summary:
Even younger adults who have few short-term risk factors for heart disease may have a higher risk of developing heart disease over their lifetimes, according to new findings.

Even younger adults who have few short-term risk factors for heart disease may have a higher risk of developing heart disease over their lifetimes, according to new findings by a UT Southwestern Medical Center researcher.

The findings, based on clinical studies and appearing in the Jan. 26 issue of the journal Circulation: Journal of the American Heart Association, suggest that traditional methods of identifying heart disease risk might not adequately identify patients who actually have a higher lifetime risk.

“We found that about half of individuals who are 50 years of age or younger and at low short-term risk for heart disease may not remain at low risk throughout their lives,” said Dr. Jarett Berry, assistant professor of internal medicine at UT Southwestern and lead author of the study.

Using current 10-year risk assessment data, more than 90 percent of patients 50 years of age and younger are considered at low risk for heart disease. But when researchers added a lifetime risk model to the 10-year risk model, they found that about half of those with a low 10-year risk but high lifetime risk had a greater progression of heart disease, as measured by buildup of coronary artery calcium and thickening of the carotid artery.

The short-term (10-year) risk factors in the study were represented by the Framingham Risk Score, a tool typically used by physicians to assess risk for heart disease in patients. Risk factors listed on the assessment include cholesterol levels, blood pressure, smoking, age and gender.

“There is a discrepancy between short-term and long-term risk,” Dr. Berry said. “People deemed low-risk, using the 10-year assessment, may not remain low-risk throughout their lives.”

About 4,000 adults younger than 50 were divided according to their short-term risk for heart disease. For those with low short-term risk and without diabetes, the researchers also estimated the lifetime risk using factors such as blood cholesterol levels, smoking and blood pressure.

“When we compared the people with low short-term but high lifetime predicted risk with those individuals who had low short-term and low lifetime predicted risk, we found that the former group had a greater prevalence and progression of atherosclerosis,” Dr. Berry said. “Thus, long-term risk estimates in younger patients may provide new information regarding risk prediction that is not usually available using only a 10-year risk model.”

Dr. Berry added that because such an estimate has a profound association with subclinical atherosclerosis at this young age, it further supports the notion that long-term risk estimation could be a useful addition to current clinical practice. In particular, a long-term risk estimate could be used in combination with a short-term risk estimate to counsel patients more effectively, especially younger adults with risk factors for heart disease.

Data from the study came from the Coronary Artery Risk Development in Young Adults (CARDIA) study and the Multi-Ethnic Study of Atherosclerosis (MESA) study, both sponsored by the National Heart, Lung and Blood Institute.

Researchers from Northwestern University, University of Minnesota, University of Alabama at Birmingham, Wake Forest University School of Medicine, Tufts University School of Medicine, Columbia University College of Physicians and Surgeons and Kaiser Permanente Northern California also contributed to this study.


Story Source:

The above story is based on materials provided by UT Southwestern Medical Center. Note: Materials may be edited for content and length.


Journal Reference:

  1. Berry JD, Liu K, Folsom AR, et al. Multi-Ethnic Study of AtherosclerosisDisease. Prevalence and progression of subclinical atherosclerosis in younger adults with low short-term but high lifetime estimated risk for cardiovascular disease. Circulation, 10.1161/CIRCULATIONAHA.108.800235

Cite This Page:

UT Southwestern Medical Center. "Healthy, Younger Adults Could Be At Risk For Heart Disease." ScienceDaily. ScienceDaily, 13 January 2009. <www.sciencedaily.com/releases/2009/01/090112201129.htm>.
UT Southwestern Medical Center. (2009, January 13). Healthy, Younger Adults Could Be At Risk For Heart Disease. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2009/01/090112201129.htm
UT Southwestern Medical Center. "Healthy, Younger Adults Could Be At Risk For Heart Disease." ScienceDaily. www.sciencedaily.com/releases/2009/01/090112201129.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins